Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs641153

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr6:31946403 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>A / G>T
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.122732 (32486/264690, TOPMED)
A=0.118198 (16560/140104, GnomAD)
A=0.098338 (11428/116212, ExAC) (+ 18 more)
A=0.09488 (7745/81628, ALFA)
A=0.09629 (2721/28258, 14KJPN)
A=0.09636 (1615/16760, 8.3KJPN)
A=0.1141 (731/6404, 1000G_30x)
A=0.1154 (578/5008, 1000G)
A=0.0627 (281/4480, Estonian)
A=0.1022 (394/3854, ALSPAC)
A=0.0939 (348/3708, TWINSUK)
A=0.0880 (257/2922, KOREAN)
A=0.1488 (189/1270, HapMap)
A=0.089 (89/998, GoNL)
A=0.132 (79/600, NorthernSweden)
A=0.142 (76/534, MGP)
A=0.102 (22/216, Qatari)
G=0.462 (48/104, SGDP_PRJ)
A=0.07 (3/40, GENOME_DK)
G=0.5 (3/6, Siberian)
A=0.5 (3/6, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
CFB : Missense Variant
Publications
92 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 97982 G=0.90020 A=0.09980 0.816905 0.016513 0.166582 32
European Sub 75636 G=0.91089 A=0.08911 0.83566 0.013882 0.150457 32
African Sub 8922 G=0.8078 A=0.1922 0.655683 0.040126 0.304192 1
African Others Sub 310 G=0.768 A=0.232 0.632258 0.096774 0.270968 5
African American Sub 8612 G=0.8092 A=0.1908 0.656526 0.038086 0.305388 0
Asian Sub 170 G=0.900 A=0.100 0.811765 0.011765 0.176471 0
East Asian Sub 114 G=0.939 A=0.061 0.894737 0.017544 0.087719 2
Other Asian Sub 56 G=0.82 A=0.18 0.642857 0.0 0.357143 1
Latin American 1 Sub 508 G=0.825 A=0.175 0.688976 0.03937 0.271654 1
Latin American 2 Sub 684 G=0.923 A=0.077 0.853801 0.008772 0.137427 0
South Asian Sub 114 G=0.877 A=0.123 0.77193 0.017544 0.210526 0
Other Sub 11948 G=0.90367 A=0.09633 0.822397 0.015065 0.162538 15


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 G=0.877268 A=0.122732
gnomAD - Genomes Global Study-wide 140104 G=0.881802 A=0.118198
gnomAD - Genomes European Sub 75916 G=0.91485 A=0.08515
gnomAD - Genomes African Sub 41950 G=0.80801 A=0.19199
gnomAD - Genomes American Sub 13646 G=0.90004 A=0.09996
gnomAD - Genomes Ashkenazi Jewish Sub 3318 G=0.9415 A=0.0585
gnomAD - Genomes East Asian Sub 3124 G=0.9353 A=0.0647
gnomAD - Genomes Other Sub 2150 G=0.8688 A=0.1312
ExAC Global Study-wide 116212 G=0.901662 A=0.098338
ExAC Europe Sub 69936 G=0.91668 A=0.08332
ExAC Asian Sub 24780 G=0.87692 A=0.12308
ExAC American Sub 11460 G=0.93656 A=0.06344
ExAC African Sub 9164 G=0.8105 A=0.1895
ExAC Other Sub 872 G=0.900 A=0.100
Allele Frequency Aggregator Total Global 81628 G=0.90512 A=0.09488
Allele Frequency Aggregator European Sub 65552 G=0.91125 A=0.08875
Allele Frequency Aggregator Other Sub 10516 G=0.90538 A=0.09462
Allele Frequency Aggregator African Sub 4084 G=0.8142 A=0.1858
Allele Frequency Aggregator Latin American 2 Sub 684 G=0.923 A=0.077
Allele Frequency Aggregator Latin American 1 Sub 508 G=0.825 A=0.175
Allele Frequency Aggregator Asian Sub 170 G=0.900 A=0.100
Allele Frequency Aggregator South Asian Sub 114 G=0.877 A=0.123
14KJPN JAPANESE Study-wide 28258 G=0.90371 A=0.09629
8.3KJPN JAPANESE Study-wide 16760 G=0.90364 A=0.09636
1000Genomes_30x Global Study-wide 6404 G=0.8859 A=0.1141
1000Genomes_30x African Sub 1786 G=0.8376 A=0.1624
1000Genomes_30x Europe Sub 1266 G=0.9115 A=0.0885
1000Genomes_30x South Asian Sub 1202 G=0.8569 A=0.1431
1000Genomes_30x East Asian Sub 1170 G=0.9402 A=0.0598
1000Genomes_30x American Sub 980 G=0.911 A=0.089
1000Genomes Global Study-wide 5008 G=0.8846 A=0.1154
1000Genomes African Sub 1322 G=0.8275 A=0.1725
1000Genomes East Asian Sub 1008 G=0.9425 A=0.0575
1000Genomes Europe Sub 1006 G=0.9135 A=0.0865
1000Genomes South Asian Sub 978 G=0.852 A=0.148
1000Genomes American Sub 694 G=0.914 A=0.086
Genetic variation in the Estonian population Estonian Study-wide 4480 G=0.9373 A=0.0627
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.8978 A=0.1022
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.9061 A=0.0939
KOREAN population from KRGDB KOREAN Study-wide 2922 G=0.9120 A=0.0880
HapMap Global Study-wide 1270 G=0.8512 A=0.1488
HapMap American Sub 556 G=0.858 A=0.142
HapMap African Sub 292 G=0.774 A=0.226
HapMap Asian Sub 248 G=0.899 A=0.101
HapMap Europe Sub 174 G=0.891 A=0.109
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 G=0.911 A=0.089
Northern Sweden ACPOP Study-wide 600 G=0.868 A=0.132
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 G=0.858 A=0.142
Qatari Global Study-wide 216 G=0.898 A=0.102
SGDP_PRJ Global Study-wide 104 G=0.462 A=0.538
The Danish reference pan genome Danish Study-wide 40 G=0.93 A=0.07
Siberian Global Study-wide 6 G=0.5 A=0.5
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 6 NC_000006.12:g.31946403G>A
GRCh38.p14 chr 6 NC_000006.12:g.31946403G>T
GRCh37.p13 chr 6 NC_000006.11:g.31914180G>A
GRCh37.p13 chr 6 NC_000006.11:g.31914180G>T
C2 RefSeqGene (LRG_26) NG_011730.1:g.23915G>A
C2 RefSeqGene (LRG_26) NG_011730.1:g.23915G>T
CFB RefSeqGene (LRG_136) NG_008191.1:g.5460G>A
CFB RefSeqGene (LRG_136) NG_008191.1:g.5460G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.3:g.3423830G>A
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.3:g.3423830G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.2:g.3423936G>A
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.2:g.3423936G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.2:g.3202378G>A
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.2:g.3202378G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.1:g.3207974G>A
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.1:g.3207974G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.2:g.3194183G>A
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.2:g.3194183G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.1:g.3199768G>A
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.1:g.3199768G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.2:g.3247592G>A
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.2:g.3247592G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.1:g.3246890G>A
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.1:g.3246890G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.2:g.3288439G>A
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.2:g.3288439G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.1:g.3294024G>A
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.1:g.3294024G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.2:g.3251380A>G
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.2:g.3251380A>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.1:g.3257000A>G
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.1:g.3257000A>T
Gene: CFB, complement factor B (plus strand)
Molecule type Change Amino acid[Codon] SO Term
CFB transcript NM_001710.6:c.95G>A R [CGG] > Q [CAG] Coding Sequence Variant
complement factor B preproprotein NP_001701.2:p.Arg32Gln R (Arg) > Q (Gln) Missense Variant
CFB transcript NM_001710.6:c.95G>T R [CGG] > L [CTG] Coding Sequence Variant
complement factor B preproprotein NP_001701.2:p.Arg32Leu R (Arg) > L (Leu) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 31114 )
ClinVar Accession Disease Names Clinical Significance
RCV000017453.4 Factor B fast/slow polymorphism Benign
RCV000017454.30 BF*FA/S Benign
RCV000017458.31 Age related macular degeneration 14 Protective
RCV000259759.4 Atypical hemolytic-uremic syndrome Benign
RCV000281261.4 Complement component 2 deficiency Likely-Benign
RCV000319518.5 Macular degeneration Benign-Likely-Benign
RCV000455762.7 not specified Benign
RCV001154197.3 Atypical hemolytic-uremic syndrome with B factor anomaly Benign
RCV001515636.7 not provided Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= A T
GRCh38.p14 chr 6 NC_000006.12:g.31946403= NC_000006.12:g.31946403G>A NC_000006.12:g.31946403G>T
GRCh37.p13 chr 6 NC_000006.11:g.31914180= NC_000006.11:g.31914180G>A NC_000006.11:g.31914180G>T
C2 RefSeqGene (LRG_26) NG_011730.1:g.23915= NG_011730.1:g.23915G>A NG_011730.1:g.23915G>T
CFB RefSeqGene (LRG_136) NG_008191.1:g.5460= NG_008191.1:g.5460G>A NG_008191.1:g.5460G>T
CFB transcript NM_001710.6:c.95= NM_001710.6:c.95G>A NM_001710.6:c.95G>T
CFB transcript NM_001710.5:c.95= NM_001710.5:c.95G>A NM_001710.5:c.95G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.3:g.3423830= NT_113891.3:g.3423830G>A NT_113891.3:g.3423830G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_COX_CTG1 NT_113891.2:g.3423936= NT_113891.2:g.3423936G>A NT_113891.2:g.3423936G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.2:g.3202378= NT_167248.2:g.3202378G>A NT_167248.2:g.3202378G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_QBL_CTG1 NT_167248.1:g.3207974= NT_167248.1:g.3207974G>A NT_167248.1:g.3207974G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.2:g.3194183= NT_167245.2:g.3194183G>A NT_167245.2:g.3194183G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_DBB_CTG1 NT_167245.1:g.3199768= NT_167245.1:g.3199768G>A NT_167245.1:g.3199768G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.2:g.3247592= NT_167249.2:g.3247592G>A NT_167249.2:g.3247592G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_SSTO_CTG1 NT_167249.1:g.3246890= NT_167249.1:g.3246890G>A NT_167249.1:g.3246890G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.2:g.3288439= NT_167247.2:g.3288439G>A NT_167247.2:g.3288439G>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MCF_CTG1 NT_167247.1:g.3294024= NT_167247.1:g.3294024G>A NT_167247.1:g.3294024G>T
GRCh38.p14 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.2:g.3251380A>G NT_167246.2:g.3251380= NT_167246.2:g.3251380A>T
GRCh37.p13 chr 6 alt locus HSCHR6_MHC_MANN_CTG1 NT_167246.1:g.3257000A>G NT_167246.1:g.3257000= NT_167246.1:g.3257000A>T
complement factor B preproprotein NP_001701.2:p.Arg32= NP_001701.2:p.Arg32Gln NP_001701.2:p.Arg32Leu
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

121 SubSNP, 22 Frequency, 9 ClinVar submissions
No Submitter Submission ID Date (Build)
1 SC_JCM ss813940 Aug 11, 2000 (83)
2 LEE ss1521836 Oct 13, 2000 (126)
3 KWOK ss1955534 Oct 18, 2000 (87)
4 PGA-UW-FHCRC ss5606986 Dec 12, 2002 (110)
5 PGA-UW-FHCRC ss12674483 Dec 05, 2003 (119)
6 SC_SNP ss15724137 Feb 27, 2004 (120)
7 CSHL-HAPMAP ss17124061 Feb 27, 2004 (120)
8 SSAHASNP ss22369263 Apr 05, 2004 (121)
9 SEQUENOM ss24796283 Sep 20, 2004 (123)
10 SI_MHC_SNP ss52084838 Oct 14, 2006 (127)
11 PERLEGEN ss68971802 May 16, 2007 (127)
12 ILLUMINA ss74878120 Dec 07, 2007 (129)
13 CORNELL ss86272822 Mar 23, 2008 (129)
14 BCMHGSC_JDW ss93436823 Mar 24, 2008 (129)
15 ILLUMINA-UK ss116395555 Feb 14, 2009 (130)
16 KRIBB_YJKIM ss119361144 Dec 01, 2009 (131)
17 SEATTLESEQ ss159712119 Dec 01, 2009 (131)
18 ILLUMINA ss160771108 Dec 01, 2009 (131)
19 COMPLETE_GENOMICS ss166431405 Jul 04, 2010 (134)
20 ILLUMINA ss173995309 Jul 04, 2010 (134)
21 BUSHMAN ss201628301 Jul 04, 2010 (134)
22 1000GENOMES ss222304984 Jul 14, 2010 (132)
23 1000GENOMES ss233399979 Jul 14, 2010 (132)
24 OMICIA ss244317409 Jun 16, 2010 (132)
25 OMIM-CURATED-RECORDS ss263198085 Nov 04, 2010 (133)
26 GMI ss278727961 May 04, 2012 (137)
27 NHLBI-ESP ss342207500 May 09, 2011 (135)
28 ILLUMINA ss481233386 May 04, 2012 (137)
29 ILLUMINA ss481256998 May 04, 2012 (137)
30 ILLUMINA ss482243198 Sep 08, 2015 (146)
31 ILLUMINA ss485412052 May 04, 2012 (137)
32 EXOME_CHIP ss491382444 May 04, 2012 (137)
33 CLINSEQ_SNP ss491885634 May 04, 2012 (137)
34 ILLUMINA ss535266941 Sep 08, 2015 (146)
35 NCBI-CURATED-RECORDS ss537713037 Jan 04, 2013 (137)
36 TISHKOFF ss559115463 Apr 25, 2013 (138)
37 SSMP ss653037226 Apr 25, 2013 (138)
38 ILLUMINA ss783151472 Aug 21, 2014 (142)
39 ILLUMINA ss784107423 Sep 08, 2015 (146)
40 ILLUMINA ss832410682 Apr 01, 2015 (144)
41 ILLUMINA ss836172976 Sep 08, 2015 (146)
42 EVA-GONL ss982769048 Aug 21, 2014 (142)
43 JMKIDD_LAB ss1067477452 Aug 21, 2014 (142)
44 JMKIDD_LAB ss1073507500 Aug 21, 2014 (142)
45 1000GENOMES ss1319567822 Aug 21, 2014 (142)
46 EVA_GENOME_DK ss1581607837 Apr 01, 2015 (144)
47 EVA_DECODE ss1592312939 Apr 01, 2015 (144)
48 EVA_UK10K_ALSPAC ss1615282766 Apr 01, 2015 (144)
49 EVA_UK10K_TWINSUK ss1658276799 Apr 01, 2015 (144)
50 EVA_EXAC ss1688243901 Apr 01, 2015 (144)
51 EVA_MGP ss1711121880 Apr 01, 2015 (144)
52 EVA_SVP ss1712851456 Apr 01, 2015 (144)
53 ILLUMINA ss1752629646 Sep 08, 2015 (146)
54 HAMMER_LAB ss1804359108 Sep 08, 2015 (146)
55 WEILL_CORNELL_DGM ss1926021174 Feb 12, 2016 (147)
56 ILLUMINA ss1958889571 Feb 12, 2016 (147)
57 ILLUMINA ss1958889572 Feb 12, 2016 (147)
58 GENOMED ss1970357990 Jul 19, 2016 (147)
59 JJLAB ss2023643901 Sep 14, 2016 (149)
60 ILLUMINA ss2094825146 Dec 20, 2016 (150)
61 USC_VALOUEV ss2151810751 Dec 20, 2016 (150)
62 HUMAN_LONGEVITY ss2282964852 Dec 20, 2016 (150)
63 SYSTEMSBIOZJU ss2626309349 Nov 08, 2017 (151)
64 ILLUMINA ss2634430880 Nov 08, 2017 (151)
65 ILLUMINA ss2634430881 Nov 08, 2017 (151)
66 ILLUMINA ss2634430882 Nov 08, 2017 (151)
67 GRF ss2707404492 Nov 08, 2017 (151)
68 GNOMAD ss2735669354 Nov 08, 2017 (151)
69 GNOMAD ss2747587483 Nov 08, 2017 (151)
70 AFFY ss2985994846 Nov 08, 2017 (151)
71 SWEGEN ss2998800995 Nov 08, 2017 (151)
72 ILLUMINA ss3022600674 Nov 08, 2017 (151)
73 ILLUMINA ss3022600675 Nov 08, 2017 (151)
74 BIOINF_KMB_FNS_UNIBA ss3025608920 Nov 08, 2017 (151)
75 ILLUMINA ss3629505624 Oct 12, 2018 (152)
76 ILLUMINA ss3632349292 Oct 12, 2018 (152)
77 ILLUMINA ss3634138335 Oct 12, 2018 (152)
78 ILLUMINA ss3636779021 Oct 12, 2018 (152)
79 ILLUMINA ss3638620560 Oct 12, 2018 (152)
80 ILLUMINA ss3643561996 Oct 12, 2018 (152)
81 OMUKHERJEE_ADBS ss3646335122 Oct 12, 2018 (152)
82 ILLUMINA ss3653113514 Oct 12, 2018 (152)
83 ILLUMINA ss3653113515 Oct 12, 2018 (152)
84 EGCUT_WGS ss3666715384 Jul 13, 2019 (153)
85 EVA_DECODE ss3716914328 Jul 13, 2019 (153)
86 ILLUMINA ss3726331057 Jul 13, 2019 (153)
87 ACPOP ss3733364280 Jul 13, 2019 (153)
88 ILLUMINA ss3744550415 Jul 13, 2019 (153)
89 EVA ss3764826169 Jul 13, 2019 (153)
90 ILLUMINA ss3772851653 Jul 13, 2019 (153)
91 KHV_HUMAN_GENOMES ss3807980894 Jul 13, 2019 (153)
92 EVA ss3824172542 Apr 26, 2020 (154)
93 EVA ss3825694841 Apr 26, 2020 (154)
94 EVA ss3829834290 Apr 26, 2020 (154)
95 SGDP_PRJ ss3864260301 Apr 26, 2020 (154)
96 KRGDB ss3911036908 Apr 26, 2020 (154)
97 EVA ss3986034708 Apr 26, 2021 (155)
98 VINODS ss4025209938 Apr 26, 2021 (155)
99 VINODS ss4025288072 Apr 26, 2021 (155)
100 TOPMED ss4698474130 Apr 26, 2021 (155)
101 TOMMO_GENOMICS ss5176849478 Apr 26, 2021 (155)
102 EVA ss5237022599 Apr 26, 2021 (155)
103 EVA ss5237190635 Apr 26, 2021 (155)
104 EVA ss5237394858 Apr 26, 2021 (155)
105 EVA ss5237394859 Apr 26, 2021 (155)
106 EVA ss5237645880 Oct 17, 2022 (156)
107 1000G_HIGH_COVERAGE ss5267945794 Oct 17, 2022 (156)
108 EVA ss5364738725 Oct 17, 2022 (156)
109 HUGCELL_USP ss5465678631 Oct 17, 2022 (156)
110 EVA ss5508429978 Oct 17, 2022 (156)
111 1000G_HIGH_COVERAGE ss5553605813 Oct 17, 2022 (156)
112 EVA ss5623935796 Oct 17, 2022 (156)
113 SANFORD_IMAGENETICS ss5640094571 Oct 17, 2022 (156)
114 TOMMO_GENOMICS ss5714709024 Oct 17, 2022 (156)
115 EVA ss5800129171 Oct 17, 2022 (156)
116 YY_MCH ss5807310372 Oct 17, 2022 (156)
117 EVA ss5842031214 Oct 17, 2022 (156)
118 EVA ss5848651995 Oct 17, 2022 (156)
119 EVA ss5855285186 Oct 17, 2022 (156)
120 EVA ss5883253570 Oct 17, 2022 (156)
121 EVA ss5968596611 Oct 17, 2022 (156)
122 1000Genomes NC_000006.11 - 31914180 Oct 12, 2018 (152)
123 1000Genomes_30x NC_000006.12 - 31946403 Oct 17, 2022 (156)
124 The Avon Longitudinal Study of Parents and Children NC_000006.11 - 31914180 Oct 12, 2018 (152)
125 Genetic variation in the Estonian population NC_000006.11 - 31914180 Oct 12, 2018 (152)
126 ExAC NC_000006.11 - 31914180 Oct 12, 2018 (152)
127 The Danish reference pan genome NC_000006.11 - 31914180 Apr 26, 2020 (154)
128 gnomAD - Genomes NC_000006.12 - 31946403 Apr 26, 2021 (155)
129 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 4812441 (NC_000006.11:31914179:G:G 222887/246556, NC_000006.11:31914179:G:A 23669/246556)
Row 4812442 (NC_000006.11:31914179:G:G 246555/246556, NC_000006.11:31914179:G:T 1/246556)

- Jul 13, 2019 (153)
130 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 4812441 (NC_000006.11:31914179:G:G 222887/246556, NC_000006.11:31914179:G:A 23669/246556)
Row 4812442 (NC_000006.11:31914179:G:G 246555/246556, NC_000006.11:31914179:G:T 1/246556)

- Jul 13, 2019 (153)
131 Genome of the Netherlands Release 5 NC_000006.11 - 31914180 Apr 26, 2020 (154)
132 HapMap NC_000006.12 - 31946403 Apr 26, 2020 (154)
133 KOREAN population from KRGDB NC_000006.11 - 31914180 Apr 26, 2020 (154)
134 Medical Genome Project healthy controls from Spanish population NC_000006.11 - 31914180 Apr 26, 2020 (154)
135 Northern Sweden NC_000006.11 - 31914180 Jul 13, 2019 (153)
136 Qatari NC_000006.11 - 31914180 Apr 26, 2020 (154)
137 SGDP_PRJ NC_000006.11 - 31914180 Apr 26, 2020 (154)
138 Siberian NC_000006.11 - 31914180 Apr 26, 2020 (154)
139 8.3KJPN NC_000006.11 - 31914180 Apr 26, 2021 (155)
140 14KJPN NC_000006.12 - 31946403 Oct 17, 2022 (156)
141 TopMed NC_000006.12 - 31946403 Apr 26, 2021 (155)
142 UK 10K study - Twins NC_000006.11 - 31914180 Oct 12, 2018 (152)
143 ALFA NC_000006.12 - 31946403 Apr 26, 2021 (155)
144 ClinVar RCV000017453.4 Oct 17, 2022 (156)
145 ClinVar RCV000017454.30 Oct 17, 2022 (156)
146 ClinVar RCV000017458.31 Oct 17, 2022 (156)
147 ClinVar RCV000259759.4 Oct 17, 2022 (156)
148 ClinVar RCV000281261.4 Oct 17, 2022 (156)
149 ClinVar RCV000319518.5 Oct 17, 2022 (156)
150 ClinVar RCV000455762.7 Oct 17, 2022 (156)
151 ClinVar RCV001154197.3 Oct 17, 2022 (156)
152 ClinVar RCV001515636.7 Oct 17, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1130150 Mar 10, 2006 (126)
rs113153662 May 09, 2011 (134)
rs115388724 Oct 26, 2010 (133)
rs150343783 Aug 12, 2011 (135)
rs281865546 Jan 07, 2013 (136)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss93436823, ss116395555, ss166431405, ss201628301, ss278727961, ss481233386, ss491885634, ss1592312939, ss1712851456, ss3643561996 NC_000006.10:32022158:G:A NC_000006.12:31946402:G:A (self)
31335646, 17472894, 12453632, 8270127, 7772776, 7767617, 18214302, 237640, 6649145, 8063104, 16277281, 4327105, 34818785, 17472894, ss222304984, ss233399979, ss342207500, ss481256998, ss482243198, ss485412052, ss491382444, ss535266941, ss559115463, ss653037226, ss783151472, ss784107423, ss832410682, ss836172976, ss982769048, ss1067477452, ss1073507500, ss1319567822, ss1581607837, ss1615282766, ss1658276799, ss1688243901, ss1711121880, ss1752629646, ss1804359108, ss1926021174, ss1958889571, ss1958889572, ss1970357990, ss2023643901, ss2094825146, ss2151810751, ss2626309349, ss2634430880, ss2634430881, ss2634430882, ss2707404492, ss2735669354, ss2747587483, ss2985994846, ss2998800995, ss3022600674, ss3022600675, ss3629505624, ss3632349292, ss3634138335, ss3636779021, ss3638620560, ss3646335122, ss3653113514, ss3653113515, ss3666715384, ss3733364280, ss3744550415, ss3764826169, ss3772851653, ss3824172542, ss3825694841, ss3829834290, ss3864260301, ss3911036908, ss3986034708, ss5176849478, ss5237394859, ss5364738725, ss5508429978, ss5623935796, ss5640094571, ss5800129171, ss5842031214, ss5848651995, ss5968596611 NC_000006.11:31914179:G:A NC_000006.12:31946402:G:A (self)
RCV000017453.4, RCV000017454.30, RCV000017458.31, RCV000259759.4, RCV000281261.4, RCV000319518.5, RCV000455762.7, RCV001154197.3, RCV001515636.7, 41131748, 221292525, 3100826, 48546128, 535851688, 10735652597, ss263198085, ss537713037, ss2282964852, ss3025608920, ss3716914328, ss3726331057, ss3807980894, ss4698474130, ss5237022599, ss5237190635, ss5237645880, ss5267945794, ss5465678631, ss5553605813, ss5714709024, ss5807310372, ss5855285186, ss5883253570 NC_000006.12:31946402:G:A NC_000006.12:31946402:G:A (self)
ss15724137, ss17124061, ss22369263 NT_007592.13:22768642:A:A NC_000006.12:31946402:G:A (self)
ss813940, ss1521836, ss1955534, ss5606986, ss12674483, ss24796283, ss52084838, ss68971802, ss74878120, ss86272822, ss119361144, ss159712119, ss160771108, ss173995309 NT_007592.15:31854179:G:A NC_000006.12:31946402:G:A (self)
ss4025209938 NT_167245.2:3194182:G:A NC_000006.12:31946402:G:A (self)
ss4025288072 NT_167249.2:3247591:G:A NC_000006.12:31946402:G:A (self)
ss2735669354, ss5237394858 NC_000006.11:31914179:G:T NC_000006.12:31946402:G:T (self)
ss244317409 NC_000006.12:31946402:G:T NC_000006.12:31946402:G:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

92 citations for rs641153
PMID Title Author Year Journal
2249879 Molecular characterization of human complement factor B subtypes. Davrinche C et al. 1990 Immunogenetics
3315100 The molecular genetics and polymorphism of C2 and factor B. Campbell RD et al. 1987 British medical bulletin
8181962 Human factor B. Complete cDNA sequence of the BF*S allele. Mejía JE et al. 1994 Human immunology
16518403 Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Gold B et al. 2006 Nature genetics
16936732 Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Maller J et al. 2006 Nature genetics
17917691 Genetic markers and biomarkers for age-related macular degeneration. Ross RJ et al. 2007 Expert review of ophthalmology
18806293 Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). Richardson AJ et al. 2009 Investigative ophthalmology & visual science
18806297 Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. McKay GJ et al. 2009 Investigative ophthalmology & visual science
19117936 Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Seddon JM et al. 2009 Investigative ophthalmology & visual science
19169232 Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. Farwick A et al. 2009 Eye (London, England)
19187590 Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chu J et al. 2008 Chinese medical journal
19556007 Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology. Kondo N et al. 2009 Ophthalmology
19661236 Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Reynolds R et al. 2009 Investigative ophthalmology & visual science
19696172 The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Kaur I et al. 2010 Investigative ophthalmology & visual science
19838195 A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Gateva V et al. 2009 Nature genetics
19844262 Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Sobrin L et al. 2010 European journal of human genetics
19899988 Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population. Pei XT et al. 2009 Current eye research
19933179 Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Edwards DR et al. 2010 Investigative ophthalmology & visual science
20157618 Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. McKay GJ et al. 2010 Molecular vision
20385826 Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Neale BM et al. 2010 Proceedings of the National Academy of Sciences of the United States of America
20861866 Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration. Kopplin LJ et al. 2010 Genes and immunity
20888482 Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Reynolds R et al. 2010 Ophthalmology
21045241 Age-related macular degeneration: genetic and environmental factors of disease. Chen Y et al. 2010 Molecular interventions
21139980 Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Seddon JM et al. 2010 Molecular vision
21179236 Analysis of candidate genes for macular telangiectasia type 2. Parmalee NL et al. 2010 Molecular vision
21394116 Complement in age-related macular degeneration: a focus on function. Bradley DT et al. 2011 Eye (London, England)
21402993 Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Chen Y et al. 2011 Archives of ophthalmology (Chicago, Ill.
21407270 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Janssens AC et al. 2011 European journal of human genetics
21424820 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Janssens AC et al. 2011 European journal of epidemiology
21447678 Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Yu Y et al. 2011 Investigative ophthalmology & visual science
21455292 Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. Spencer KL et al. 2011 PloS one
21541267 Complement factor B polymorphism 32W protects against age-related macular degeneration. Hughes AE et al. 2011 Molecular vision
21555552 Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Heurich M et al. 2011 Proceedings of the National Academy of Sciences of the United States of America
21620475 Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Seddon JM et al. 2011 Ophthalmology
21665990 Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Yu Y et al. 2011 Human molecular genetics
21797996 Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability. Mihaescu R et al. 2011 Genome medicine
21807600 Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hageman GS et al. 2011 Human genomics
21959373 Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Seddon JM et al. 2011 Ophthalmology
22046141 Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. Cunninghame Graham DS et al. 2011 PLoS genetics
22247473 Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Yu Y et al. 2012 Investigative ophthalmology & visual science
22273503 Association of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population. Kim SJ et al. 2012 Experimental eye research
22324898 Genetics of immunological and inflammatory components in age-related macular degeneration. Tuo J et al. 2012 Ocular immunology and inflammation
22440158 CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. Sun C et al. 2012 Current eye research
22666427 Modelling the genetic risk in age-related macular degeneration. Grassmann F et al. 2012 PloS one
22678500 Genetic factors for choroidal neovascularization associated with high myopia. Leveziel N et al. 2012 Investigative ophthalmology & visual science
22694956 Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Cipriani V et al. 2012 Human molecular genetics
22705344 Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Sobrin L et al. 2012 Ophthalmology
23112567 Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population. Buentello-Volante B et al. 2012 Molecular vision
23373431 Complement factor B polymorphism and the phenotype of early age-related macular degeneration. Mantel I et al. 2014 Ophthalmic genetics
23481534 Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Reynolds R et al. 2013 Ophthalmology
23523162 Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Perlee LT et al. 2013 Ophthalmology
23577725 Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis. Naj AC et al. 2013 Annals of human genetics
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
23919682 Complement alternative pathway genetic variation and Dengue infection in the Thai population. Kraivong R et al. 2013 Clinical and experimental immunology
24033266 A systematic approach to assessing the clinical significance of genetic variants. Duzkale H et al. 2013 Clinical genetics
24120328 Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium. Buitendijk GHS et al. 2013 Ophthalmology
24289920 Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Yehoshua Z et al. 2014 Ophthalmology
24369445 Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Parmeggiani F et al. 2013 Mediators of inflammation
24498017 Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. Seddon JM et al. 2014 PloS one
24652797 Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign? Marinozzi MC et al. 2014 Journal of the American Society of Nephrology
24675670 Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels. Ristau T et al. 2014 PloS one
24860613 Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy. Kuo JZ et al. 2013 Expert review of ophthalmology
24865190 Association of specific genetic polymorphisms with age-related macular degeneration in a northern Chinese population. Zhuang W et al. 2014 Ophthalmic genetics
25132797 Using current data to define new approach in age related macular degeneration: need to accelerate translational research. Anand A et al. 2014 Current genomics
25276841 Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue. Kawa MP et al. 2014 Journal of immunology research
25478207 Age-related macular degeneration: insights into inflammatory genes. Cascella R et al. 2014 Journal of ophthalmology
25558172 Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients. Park UC et al. 2014 Molecular vision
26255974 A Validated Phenotyping Algorithm for Genetic Association Studies in Age-related Macular Degeneration. Simonett JM et al. 2015 Scientific reports
26490493 Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Merle BM et al. 2015 The American journal of clinical nutrition
26961928 Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Merle BM et al. 2016 The American journal of clinical nutrition
27239555 Oxidative stress, innate immunity, and age-related macular degeneration. Shaw PX et al. 2016 AIMS molecular science
27241480 A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo. Paun CC et al. 2016 Scientific reports
27252648 AMD Genetics in India: The Missing Links. Anand A et al. 2016 Frontiers in aging neuroscience
27257685 Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages. Schick T et al. 2016 PloS one
27258093 Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration. Saksens NT et al. 2016 PloS one
27759029 A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility. Gupta A et al. 2016 European journal of human genetics
27832277 Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus. Sardell RJ et al. 2016 Investigative ophthalmology & visual science
29288272 Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions - The Weisenfeld Award Lecture. Seddon JM et al. 2017 Investigative ophthalmology & visual science
29453225 Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population. Connolly E et al. 2018 The British journal of ophthalmology
29700787 Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration. Lorés-Motta L et al. 2018 Molecular diagnosis & therapy
30179527 Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis. Lu F et al. 2018 Genetic testing and molecular biomarkers
30225264 Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine. Maugeri A et al. 2018 BioMed research international
30389371 Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals. Seddon JM et al. 2019 American journal of ophthalmology
30450319 New insight into the role of the complement in the most common types of retinopathy-current literature review. Chrzanowska M et al. 2018 International journal of ophthalmology
30974970 Complement factor B gene polymorphisms and risk of age-related macular degeneration: A meta-analysis. Su Y et al. 2020 European journal of ophthalmology
31118930 Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS. Valoti E et al. 2019 Frontiers in immunology
32407518 Genetic Susceptibility, Diet Quality, and Two-Step Progression in Drusen Size. Merle BMJ et al. 2020 Investigative ophthalmology & visual science
33334325 A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population. Seo JY et al. 2020 BMC medical genetics
33371261 Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration. Jensen EG et al. 2020 International journal of molecular sciences
33765843 Gene polymorphisms associated with an increased risk of exudative age-related macular degeneration in a Spanish population. Gili P et al. 2022 European journal of ophthalmology
34750590 The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD. Khan AH et al. 2022 Eye (London, England)
34945728 Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration. Acar IE et al. 2021 Journal of personalized medicine
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d